Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-06-28 Sale | 2024-07-02 4:54 pm | TELA Bio Inc. | TELA | ORBIMED ADVISORS LLC OrbiMed Capital GP IV LLC 10% Owner | 428,300 | $4.721 | $2,022,000 | 2,407,242 (Indirect) | View |
2023-04-19 Sale | 2023-04-21 5:08 pm | TELA Bio Inc. | TELA | ORBIMED ADVISORS LLC OrbiMed Capital GP IV LLC 10% Owner | 192,000 | $9.335 | $1,792,326 | 2,835,542 (Indirect) | View |
2021-07-19 Purchase | 2021-07-21 5:30 pm | Acutus Medical Inc. | AFIB | ORBIMED ADVISORS LLC OrbiMed Capital GP IV LLC Orbimed ROF II LLC Director 10% Owner | 1,071,428 | $14 | $14,999,992 | 1,681,383 (Indirect) | View |
2020-08-10 Purchase | 2020-08-12 9:06 pm | Acutus Medical Inc. | AFIB | ORBIMED ADVISORS LLC OrbiMed Capital GP IV LLC Orbimed ROF II LLC Director 10% Owner | 415,000 | $18 | $7,470,000 | 1,320,218 (Indirect) | View |
2020-04-14 Sale | 2020-04-16 8:23 pm | Alector Inc. | ALEC | ORBIMED ADVISORS LLC OrbiMed Capital GP IV LLC 10% Owner | 85,414 | $23.53 | $2,009,559 | 1,906,718 (Indirect) | View |
2020-04-07 Sale | 2020-04-09 5:30 pm | Alector Inc. | ALEC | ORBIMED ADVISORS LLC OrbiMed Capital GP IV LLC 10% Owner | 379,885 | $23.74 | $9,019,571 | 1,927,440 (Indirect) | View |
2020-03-31 Sale | 2020-04-02 5:06 pm | Alector Inc. | ALEC | ORBIMED ADVISORS LLC OrbiMed Capital GP IV LLC 10% Owner | 250,000 | $24.5 | $6,125,000 | 2,019,598 (Indirect) | View |
2020-03-23 Sale | 2020-03-25 5:54 pm | Alector Inc. | ALEC | ORBIMED ADVISORS LLC OrbiMed Capital GP IV LLC 10% Owner | 138,653 | $24.7 | $3,425,269 | 2,080,243 (Indirect) | View |
2020-03-02 Sale | 2020-03-04 4:17 pm | Alector Inc. | ALEC | ORBIMED ADVISORS LLC OrbiMed Capital GP IV LLC ORBIMED CAPITAL LLC 10% Owner | 1,874,203 | $26 | $48,729,278 | 0 (Indirect) | View |
2020-01-09 Sale | 2020-01-13 4:48 pm | Alector Inc. | ALEC | ORBIMED ADVISORS LLC OrbiMed Capital GP IV LLC ORBIMED CAPITAL LLC 10% Owner | 379,997 | $19.5 | $7,409,942 | 38,808 (Indirect) | View |
2019-12-20 Sale | 2019-12-26 4:54 pm | Alector Inc. | ALEC | ORBIMED ADVISORS LLC OrbiMed Capital GP IV LLC ORBIMED CAPITAL LLC 10% Owner | 519,385 | $19.66 | $10,209,721 | 40,200 (Indirect) | View |
2019-12-17 Sale | 2019-12-19 4:33 pm | Alector Inc. | ALEC | ORBIMED ADVISORS LLC OrbiMed Capital GP IV LLC ORBIMED CAPITAL LLC 10% Owner | 954,100 | $18.52 | $17,669,932 | 97,700 (Indirect) | View |
2019-11-08 Purchase | 2019-11-13 8:47 pm | TELA Bio Inc. | TELA | ORBIMED ADVISORS LLC OrbiMed Capital GP IV LLC 10% Owner | 384,615 | $13 | $4,999,995 | 3,786,165 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2020-08-10 Conversion | 2020-08-12 9:06 pm | N/A N/A | Acutus Medical Inc. | AFIB | ORBIMED ADVISORS LLC OrbiMed Capital GP IV LLC Orbimed ROF II LLC Director 10% Owner | 10,125,916 | $0 | 1,320,218 (Indirect) | View |
Ownership | 2020-08-05 9:04 pm | N/A N/A | Acutus Medical Inc. | AFIB | ORBIMED ADVISORS LLC OrbiMed Capital GP IV LLC Orbimed ROF II LLC Director 10% Owner | 0 | $0 | 5,395,525 (Indirect) | View |
2019-11-13 Conversion | 2019-11-13 8:47 pm | N/A N/A | TELA Bio Inc. | TELA | ORBIMED ADVISORS LLC OrbiMed Capital GP IV LLC 10% Owner | 38,996,829 | $0 | 3,786,165 (Direct) | View |
Ownership | 2019-11-07 9:02 pm | 2017-01-18 2027-01-18 | TELA Bio Inc. | TELA | ORBIMED ADVISORS LLC OrbiMed Capital GP IV LLC 10% Owner | 0 | $0 | 2,217,538 (Direct) | View |